Skip to main content
Equibles

MEEDER ASSET MANAGEMENT INC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 809443 DUBLIN, OH
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,462,048
-$246,417 QoQ
Shares Held
7,156
+17.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MEEDER ASSET MANAGEMENT INC holds $6,513,506 across 35 Biotechnology names. REGN ranks #1 (68.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page 		7,156 $4,462,048
2 CAI
Caris Life Sciences, Inc.
 34,035 $606,501
3 ALNY
Alnylam Pharmaceuticals, Inc.
 1,570 $472,613
4 CLDX
Celldex Therapeutics, Inc.
 5,009 $186,384
5 TWST
Twist Bioscience Corp
 1,571 $161,624
6 MNPR
Monopar Therapeutics
 1,389 $128,607
7 RAPP
Rapport Therapeutics, Inc.
 2,774 $115,592
8 CRVS
Corvus Pharmaceuticals, Inc.
 6,055 $90,461

All Filings in REGN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,462,048 7,156
2026-03-31 $4,708,465 6,094
2025-12-31 $4,185,847 5,423
2025-09-30 $2,547,079 4,530
2025-06-30 $2,958,900 5,636
2025-03-31 $12,684 20
2024-12-31 $21,369 30
2024-09-30 $214,452 204
2024-06-30 $28,377 27
2024-03-31 $231,959 241
2023-06-30 $11,496 16
2023-03-31 $3,966,199 4,827
2022-12-31 $3,506,438 4,860
2022-09-30 $4,182,815 6,072
2022-06-30 $4,192,881 7,093
2022-03-31 $4,527,853 6,483
2021-12-31 $9,214,505 14,591
2021-09-30 $10,156,732 16,783
2021-06-30 $8,499,861 15,218
2021-03-31 $8,080,282 17,078
2020-12-31 $191,311 396
2020-09-30 $2,700,935 4,825
2020-06-30 $2,969,195 4,761
2020-03-31 $2,329,139 4,770